 Prolonged reversible quadriparesis ventilated patients long-term infusions vecuronium use neuromuscular agents pancuronium patients mechanical ventilation prolonged paralysis atrophy ventilated patients asthma prolonged muscular weakness atrophy shorter-acting agent vecuronium cases potential neuromuscular blocking agent complications patients immobile renal liver function concomitant myotoxic agents